Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Sep 20:10:2251.
doi: 10.3389/fimmu.2019.02251. eCollection 2019.

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

Affiliations
Review

The Quest for Cellular Markers of HIV Reservoirs: Any Color You Like

Gilles Darcis et al. Front Immunol. .

Abstract

Combination antiretroviral therapy (ART) suppresses human immunodeficiency virus (HIV) replication and improves immune function, but is unable to eradicate the virus. Therefore, development of an HIV cure has become one of the main priorities of the HIV research field. The main obstacle for an HIV cure is the formation of latent viral reservoirs, where the virus is able to "hide" despite decades of therapy, just to reignite active replication once therapy is stopped. Revealing HIV hiding places is thus central to HIV cure research, but the absence of markers of these reservoir cells greatly complicates the search for a cure. Identification of one or several marker(s) of latently infected cells would represent a significant step forward toward a better description of the cell types involved and improved understanding of HIV latency. Moreover, it could provide a "handle" for selective therapeutic targeting of the reservoirs. A number of cellular markers of HIV reservoir have recently been proposed, including immune checkpoint molecules, CD2, and CD30. CD32a is perhaps the most promising of HIV reservoir markers as it is reported to be associated with a very prominent enrichment in HIV DNA, although this finding has been challenged. In this review, we provide an update on the current knowledge about HIV reservoir markers. We specifically highlight studies that characterized markers of persistently infected cells in the lymphoid tissues.

Keywords: HIV; HIV latent reservoir; HIV persistence; biomarker; viral reservoirs.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Presence of residual non-CD4+ T cells in the CD32+ cell fraction. (A) After one round of selection for CD4+ T cells, although the residual non-CD4+ T-cell contamination is low in general, the percentage of CD32+ cells among non-T cells is much higher than among CD4+ T cells. Therefore, after selection for CD32-expressing cells, the majority of CD32+ cells will be non-T cells. (B) Two consecutive rounds of CD4+ T-cell selection result in much purer CD4+ T-cell population, and the majority of CD4+ T cells is maintained even in the CD32+ fraction.

References

    1. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, Taylor H, et al. . Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature. (1997) 387:183–8. 10.1038/387183a0 - DOI - PubMed
    1. Chun TW, Finzi D, Margolick J, Chadwick K, Schwartz D, Siliciano RF. In vivo fate of HIV-1-infected T cells: quantitative analysis of the transition to stable latency. Nat Med. (1995) 1:1284–90. 10.1038/nm1295-1284 - DOI - PubMed
    1. Finzi D, Blankson J, Siliciano JD, Margolick JB, Chadwick K, Pierson T, et al. . Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat Med. (1999) 5:512–7. 10.1038/8394 - DOI - PubMed
    1. Siliciano JD, Kajdas J, Finzi D, Quinn TC, Chadwick K, Margolick JB, et al. . Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat Med. (2003) 9:727–8. 10.1038/nm880 - DOI - PubMed
    1. Chun TW, Davey RT, Jr, Ostrowski M, Shawn Justement J, Engel D, Mullins JI, et al. . Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nat Med. (2000) 6:757–61. 10.1038/77481 - DOI - PubMed

Publication types